HomeMCRB • NASDAQ
add
Seres Therapeutics Inc
Previous close
$9.05
Day range
$8.60 - $9.10
Year range
$6.54 - $29.98
Market cap
78.07M USD
Avg Volume
87.57K
P/E ratio
14.65
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 438.00K | — |
Operating expense | 22.64M | -4.50% |
Net income | -15.34M | 1.93% |
Net profit margin | -3.50K | — |
Earnings per share | -1.76 | 20.00% |
EBITDA | -18.33M | 33.94% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 45.77M | 48.62% |
Total assets | 138.19M | -1.16% |
Total liabilities | 93.98M | -25.43% |
Total equity | 44.22M | — |
Shares outstanding | 9.56M | — |
Price to book | 1.95 | — |
Return on assets | -34.40% | — |
Return on capital | -37.83% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -15.34M | 1.93% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2010
Website
Employees
103
